A 1 Virtanen Institute for Molecular Sciences University of Eastern Finland Kuopio Finland

Basel Muscle MRI Department of Biomedical Engineering University of Basel Basel Switzerland

Center for Stroke Research Berlin Charité Universitätsmedizin Berlin Berlin Germany

Centre for Cardiovascular Sciences and Edinburgh Imaging University of Edinburgh Edinburgh UK

Charité Universitätsmedizin Berlin Berlin Germany

Department of Bioengineering Instituto Superior Técnico Universidade de Lisboa Lisbon Portugal

Department of Biology University of York York UK

Department of Chemistry Faculty of Mathematics and Natural Sciences University of Cologne Cologne Germany

Department of Diagnostic and Interventional Radiology Institute for Clinical and Experimental Medicine Prague Czech Republic

Department of Diagnostic and Interventional Radiology University of Leipzig Leipzig Germany

Department of Neuroradiology AP HP Pitié Salpêtrière Hospital Paris France

Department of Radiation Oncology Hospital Universitario San Francisco de Asís Hospital Universitario Vithas La Milagrosa GenesisCare 28010 Madrid Spain

Department of Radiology Clínica Girona Institute of Diagnostic Imaging Girona University of Girona 17004 Girona Spain

Department of Radiology University Hospital of Basel Basel Switzerland

Department of Sports and Exercise Science Institute of Sport Manchester Metropolitan University Manchester UK

Early Clinical Development Genentech Inc South San Francisco USA

Experimental and Clinical Research Center A Joint Cooperation Between the Charité Medical Faculty and the MDC Berlin Germany

Experimental Cardiovascular Imaging Institute for Molecular Cardiology Heinrich Heine University Düsseldorf Düsseldorf Germany

Institute for Systems and Robotics ISR Lisboa Lisbon Portugal

Institute of Diagnostic and Interventional Radiology Faculty of Medicine University Hospital of Cologne University of Cologne Cologne Germany

Max Delbrück Centrum Für Molekulare Medizin Berlin Ultrahigh Field Facility Berlin Germany

Minimally Invasive Image Guided Intervention Center Department of Medical Imaging Radboudumc Nijmegen The Netherlands

Neuroscience Research Center Department of Medical and Surgical Sciences Università Degli Studi Magna Graecia Catanzaro Italy

Sorbonne Université Inserm CNRS UMR S 1127 Paris Brain Institute ICM Paris France

Translational Research Imaging Center Clinic of Radiology University of Münster Münster Germany

Unit of Diagnostic and Interventional Neuroradiology Diagnostic Department University Hospitals of Geneva Geneva Switzerland

Erratum v

MAGMA. 2024 Oct;37(5):947-948. doi: 10.1007/s10334-024-01201-7. PubMed

Zobrazit více v PubMed

Zhang Z et al (2022) Theranostics for MRI-guided therapy: recent developments. VIEW 3(3):20200134

Weber WA et al (2023) What is theranostics? J Nucl Med 64(5):669–670 PubMed

Thompson SM et al (2021) Body interventional MRI for diagnostic and interventional radiologists: current practice and future prospects. Radiographics 41(6):1785–1801 PubMed

Vilanova JC et al (2020) Robotic-assisted transrectal MRI-guided biops. Technical feasibility and role in the current diagnosis of prostate cancer: an initial single-center experience. Abdom Radiol 45(12):4150–4159 PubMed

Aviles-Olmos I et al (2014) Long-term outcome of subthalamic nucleus deep brain stimulation for Parkinson’s disease using an MRI-guided and MRI-verified approach. J Neurol Neurosurg Psychiatry 85(12):1419–1425 PubMed PMC

Maxouri O et al (2023) How to 19F MRI: applications, technique, and getting started. BJR Open 5(1):20230019 PubMed PMC

Temme S et al (2015) Noninvasive imaging of early venous thrombosis by 19F magnetic resonance imaging with targeted perfluorocarbon nanoemulsions. Circulation 131(16):1405–1414 PubMed

Flögel U et al (2021) Multi-targeted 1H/19F MRI unmasks specific danger patterns for emerging cardiovascular disorders. Nat Commun 12(1):5847 PubMed PMC

Flögel U et al (2012) Selective activation of adenosine A2A receptors on immune cells by a CD73-dependent prodrug suppresses joint inflammation in experimental rheumatoid arthritis. Sci Transl Med 4(146):146ra108 PubMed

Flögel U et al (2008) In vivo monitoring of inflammation after cardiac and cerebral ischemia by fluorine magnetic resonance imaging. Circulation 118(2):140–148 PubMed PMC

Bouvain P et al (2023) Non-invasive mapping of systemic neutrophil dynamics upon cardiovascular injury. Nat Cardiovasc Res 2(2):126–143 PubMed PMC

Starke L et al (2023) First in vivo fluorine-19 magnetic resonance imaging of the multiple sclerosis drug siponimod. Theranostics 13(4):1217–1234 PubMed PMC

Ding M, Liu W, Gref R (2022) Nanoscale MOFs: from synthesis to drug delivery and theranostics applications. Adv Drug Deliv Rev 190:114496 PubMed

Frantellizzi V et al (2020) New frontiers in molecular imaging with superparamagnetic iron oxide nanoparticles (SPIONs): efficacy, toxicity, and future applications. Nucl Med Mol Imaging 54(2):65–80 PubMed PMC

Arifin DR, Bulte JWM (2021) In vivo imaging of pancreatic islet grafts in diabetes treatment. Front Endocrinol (Lausanne) 12:640117 PubMed PMC

Saudek F et al (2010) Magnetic resonance imaging of pancreatic islets transplanted into the liver in humans. Transplantation 90(12):1602–1606 PubMed

Berkova Z et al (2008) Labeling of pancreatic islets with iron oxide nanoparticles for in vivo detection with magnetic resonance. Transplantation 85(1):155–159 PubMed

Waiczies S, Niendorf T, Lombardi G (2017) Labeling of cell therapies: How can we get it right? Oncoimmunology 6:e1345403 PubMed PMC

Gomes Marin JF et al (2020) Theranostics in nuclear medicine: emerging and re-emerging integrated imaging and therapies in the era of precision oncology. Radiographics 40(6):1715–1740 PubMed

Scarborough J et al (2020) Preclinical validation of the micropipette-guided drug administration (MDA) method in the maternal immune activation model of neurodevelopmental disorders. Brain Behav Immun 88:461–470 PubMed

Pala R et al (2021) Nanomaterials as novel cardiovascular theranostics. Pharmaceutics 13(3):348 PubMed PMC

Simó C et al (2024) Urease-powered nanobots for radionuclide bladder cancer therapy. Nat Nanotechnol 19:554–564 PubMed PMC

Hapuarachchige S, Artemov D (2020) Theranostic pretargeting drug delivery and imaging platforms in cancer precision medicine. Front Oncol. 10.3389/fonc.2020.01131 PubMed PMC

Louis DN et al (2021) The 2021 WHO classification of tumors of the central nervous system: a summary. Neuro Oncol 23(8):1231–1251 PubMed PMC

Dang L et al (2009) Cancer-associated IDH1 mutations produce 2-hydroxyglutarate. Nature 462(7274):739–744 PubMed PMC

Branzoli F et al (2019) Cystathionine as a marker for 1p/19q codeleted gliomas by in vivo magnetic resonance spectroscopy. Neuro Oncol 21(6):765–774 PubMed PMC

Branzoli F, Marjanska M (2020) Magnetic resonance spectroscopy of isocitrate dehydrogenase mutated gliomas: current knowledge on the neurochemical profile. Curr Opin Neurol 33(4):413–421 PubMed PMC

Fear EJ et al (2022) SABRE hyperpolarized anticancer agents for use in 1H MRI. Magn Reson Med 88(1):11–27 PubMed PMC

van Zijl PCM et al (2021) Hyperpolarized MRI, functional MRI, MR spectroscopy and CEST to provide metabolic information in vivo. Curr Opin Chem Biol 63:209–218 PubMed PMC

Ardenkjaer-Larsen JH et al (2003) Increase in signal-to-noise ratio of > 10,000 times in liquid-state NMR. Proc Natl Acad Sci U S A 100(18):10158–10163 PubMed PMC

Bowers CR, Weitekamp DP (1987) Parahydrogen and synthesis allow dramatically enhanced nuclear alignment. J Am Chem Soc 109(18):5541–5542

Adams RW et al (2009) Reversible interactions with para-hydrogen enhance NMR sensitivity by polarization transfer. Science 323(5922):1708–1711 PubMed

Riegler J et al (2010) Targeted magnetic delivery and tracking of cells using a magnetic resonance imaging system. Biomaterials 31(20):5366–5371 PubMed

Muthana M et al (2015) Directing cell therapy to anatomic target sites in vivo with magnetic resonance targeting. Nat Commun 6(1):8009 PubMed PMC

Barkhausen J et al (2017) White paper: interventional MRI: current status and potential for development considering economic perspectives, part 1: general application. Rofo 189(7):611–623 PubMed

Barkhausen J et al (2017) White paper: interventional MRI: current status and potential for development considering economic perspectives, part 2: liver and other applications in oncology. Rofo 189(11):1047–1054 PubMed

van Luijtelaar A, Futterer JJ, Bomers JG (2022) Minimally invasive magnetic resonance image-guided prostate interventions. Br J Radiol 95(1131):20210698 PubMed PMC

Wimper Y, Futterer JJ, Bomers JGR (2022) MR imaging in real time guiding of therapies in prostate cancer. Life (Basel) 12(2):302 PubMed PMC

Roosen J et al (2022) Intraprocedural MRI-based dosimetry during transarterial radioembolization of liver tumours with holmium-166 microspheres (EMERITUS-1): a phase I trial towards adaptive, image-controlled treatment delivery. Eur J Nucl Med Mol Imaging 49(13):4705–4715 PubMed PMC

Rogers CM, Jones PS, Weinberg JS (2021) Intraoperative MRI for brain tumors. J Neurooncol 151(3):479–490 PubMed

Wach J et al (2021) Intraoperative MRI-guided resection in pediatric brain tumor surgery: a meta-analysis of extent of resection and safety outcomes. J Neurol Surg A Cent Eur Neurosurg 82(1):64–74 PubMed

Eid H et al (2020) Eight-year experience with 3-T intraoperative MRI integration in focal pediatric epilepsy surgery: impact on extent of resection, residual volumes, and seizure outcomes. AJR Am J Roentgenol 214(6):1343–1351 PubMed

Na YC et al (2015) Unilateral magnetic resonance-guided focused ultrasound pallidotomy for Parkinson disease. Neurology 85(6):549–551 PubMed

Rahmathulla G et al (2012) Surgical briefings, checklists, and the creation of an environment of safety in the neurosurgical intraoperative magnetic resonance imaging suite. Neurosurg Focus 33(5):E12 PubMed

Khokhlova VA et al (2015) Histotripsy methods in mechanical disintegration of tissue: towards clinical applications. Int J Hyperthermia 31(2):145–162 PubMed PMC

Siedek F et al (2019) Magnetic resonance-guided high-intensity focused ultrasound (MR-HIFU): technical background and overview of current clinical applications (part 1). Rofo 191(6):522–530 PubMed

Siedek F et al (2019) Magnetic resonance-guided high-intensity focused ultrasound (MR-HIFU): overview of emerging applications (part 2). Rofo 191(6):531–539 PubMed

Sebeke LC et al (2021) Visualization of thermal washout due to spatiotemporally heterogenous perfusion in the application of a model-based control algorithm for MR-HIFU mediated hyperthermia. Int J Hyperthermia 38(1):1174–1187 PubMed

Winter L et al (2015) Thermal magnetic resonance: physics considerations and electromagnetic field simulations up to 23.5 Tesla (1GHz). Radiat Oncol 10:201 PubMed PMC

Titsworth WL et al (2014) Fighting fire with fire: the revival of thermotherapy for gliomas. Anticancer Res 34(2):565 PubMed

Ji Y et al (2020) Controlled release of therapeutics from thermoresponsive nanogels: a thermal magnetic resonance feasibility study. Cancers 12(6):1380 PubMed PMC

Saha N et al (2023) Advanced radio frequency applicators for thermal magnetic resonance theranostics of brain tumors. Cancers 15(8):2303 PubMed PMC

Oberacker E et al (2021) Patient-specific planning for thermal magnetic resonance of glioblastoma multiforme. Cancers 13(8):1867 PubMed PMC

Brito B et al (2021) Smart magnetic resonance imaging-based theranostics for cancer. Theranostics 11(18):8706–8737 PubMed PMC

Ocanto A et al (2024) MR-LINAC, a new partner in radiation oncology: current landscape. Cancers 16(2):270 PubMed PMC

Esmaeilpour Z et al (2020) Methodology for tDCS integration with fMRI. Hum Brain Mapp 41(7):1950–1967 PubMed PMC

Bergmann TO et al (2021) Concurrent TMS-fMRI for causal network perturbation and proof of target engagement. Neuroimage 237:118093 PubMed

Aydogan DB et al (2023) Real-time tractography-assisted neuronavigation for TMS. bioRxiv. 10.1101/2023.03.09.531565 PubMed

Nerella SG et al (2022) PET molecular imaging in drug development: the imaging and chemistry perspective. Front Med. 10.3389/fmed.2022.812270 PubMed PMC

Beckmann N et al (2004) Magnetic resonance imaging in drug discovery: lessons from disease areas. Drug Discov Today 9(1):35–42 PubMed

Kaggie JD et al (2017) Role of magnetic resonance in drug development. In: Webb GA (ed) Modern magnetic resonance. Springer International Publishing, Cham, pp 1–20

Wachsmuth L et al (2021) Contribution of preclinical MRI to responsible animal research: living up to the 3R principle. Magn Reson Mater Phy 34(4):469–474 PubMed PMC

O’Connor JPB et al (2017) Imaging biomarker roadmap for cancer studies. Nat Rev Clin Oncol 14(3):169–186 PubMed PMC

Selby NM et al (2018) Magnetic resonance imaging biomarkers for chronic kidney disease: a position paper from the European cooperation in science and technology action PARENCHIMA. Nephrol Dial Transplant 33(suppl_2):ii4–ii14 PubMed PMC

Littlejohns TJ et al (2020) The UK Biobank imaging enhancement of 100,000 participants: rationale, data collection, management and future directions. Nat Commun 11(1):2624 PubMed PMC

Weingartner S et al (2022) Development, validation, qualification, and dissemination of quantitative MR methods: Overview and recommendations by the ISMRM quantitative MR study group. Magn Reson Med 87(3):1184–1206 PubMed